| Composition |
| • | Urokinase 250000 Inj |
| • | Urokinase 2.5 L IU |
| • | Urokinase 500000 Inj |
| • | Urokinase 5 L IU |
| • | Urokinase 7.5 Inj |
| • | Urokinase 7.5 L IU |
Features |
| • | Indicated in Myocardial Infarction (MI), Coronary artery thrombosis, Pulmonary embolism, Deep vein thrombosis and Peripheral vascular thrombo - embolism |
Benefits |
| • | Offers proven life saving benefits. Can be recommended for repeat dosing unlike Streptokinase |
|
 |
| Dosage |
| • | As directed by the Physician. (Please refer the detailed product literature for contraindications, special precautions, drug interactions, adverse effects and overdose) |
Packaging |
| • | Individually packed vial containing purified Urokinase
2,50,000 i.u
5,00,000 i.u
7,50,000 i.u
10,00,000 i.u |
|
